News & Events
Combinostics’ cDSI and cMRI Applications, Part of the cNeuro Platform, Receive EC-certification Under the EU’s Medical Device Regulation (MDR)
cNeuro® cDSI™ and cNeuro cMRI™ achieve EC-certification under MDR, ensuring continued delivery of services to European customers.
Combinostics Launches Latest Version of Its cNeuro Platform
The latest version of cNeuro® includes the launch of the Dementia Differential Analysis report, new disease-specific reports, additional automated MRI quantifications and imaging biomarkers, and more.
AAIC 2022
Attending AAIC 2022? Stop by booth 400 to learn about our complete solution for early detection, diagnosis, and management of neurological disorders.
European Congress of Radiology (ECR) 2022
Attending ECR 2022? Stop by booth AI-09 to learn about our complete solution for early detection, diagnosis, and management of neurological disorders.
Combinostics Announces an Industry-First Report Supporting the Differential Diagnosis of Dementias
Our industry-first Dementia Differential Analysis report is based on MRI data only and compares the patient’s data against reference data from thousands of previous patients.
103rd German X-Ray Congress
Attending the 103rd German X-Ray Congress? Stop by booth Nord 39 to learn about our complete solution for early detection, diagnosis, and management of neurological disorders.
Tom Gardner Joins Combinostics as Vice President of US Sales
Tom Gardner has joined Combinostics as the Vice President of US Sales. He has over 25 years of experience successfully developing and leading sales teams in the AI and clinical imaging software solutions space.
ASNR 2022 Annual Meeting
Attending ASNR22? Stop by Booth #109 to learn about our complete solution for early detection, diagnosis, and management of neurological disorders.
Combinostics Selected to Progress to the Finals of neurotechprize
Combinostics has been selected by the jury to progress to the finals for the neurotechprize run by EIT Health and Biogen. The award recognizes technological innovations for the diagnosis and care of Alzheimer’s patients.
